Sanofi Buys Rolaids, Plans Product Relaunch in 2013

On Monday, pharmaceuticals giant Sanofi (NYSE: SNY  ) announced that its U.S. Consumer Healthcare Division, Chattem, has acquired the worldwide rights to the Rolaids brand from McNeil-PPC, a division of Johnson & Johnson (NYSE: JNJ  ) .

Calling Rolaids "an iconic brand" already, Chattem CEO Zan Guerry promised to grow the brand even further "through innovation and advertising ... and take the brand to a new level." The company already owns such well-known brands as Icy Hot, Gold Bond, Cortizone-10, Selsun Blue, and Unisom.

Rolaids products were pulled from store shelves in 2010  in response to concerns that some packages of the antacid had been reported to contain "foreign particles," including metal and wood. They have not been available for sale since . Buying the brand from McNeil, Sanofi says it intends to "relaunch" the brand, and begin selling Rolaids again within a year.

Sanofi shares rose 0.2% on the news, to $48.10.

 
 

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2182935, ~/Articles/ArticleHandler.aspx, 7/26/2014 1:49:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement